Associate Professor M. Derda Ozer DERDA SAGLIK HIZMETLERI
Associate Professor M. Derda Ozer DERDA SAGLIK HIZMETLERI
Turkey, Istanbul
Muhammet Derda Ozer
22 years of experience • 25000+ treatments performed
Clinic is certified :
Stem cell therapy for retina in Turkey typically costs from AUD $14,353 to AUD $22,964. Total investment depends on the cell source, the number of sessions, and whether one or both eyes require treatment. In Australia, this specialised therapy is rarely available and can cost AUD $28,705 on average. Patients save approximately 35% by choosing Turkish clinics. Most packages cover ophthalmologist consultations, retinal imaging, hospital stays, and airport transfers.
Bookimed Expert Insight: Choosing a specialised eye centre provides significant value. For example, Dunyagoz Eye Hospital Istanbul Etiler treats 66,000 patients annually. They offer packages around A$21,100 including hospital stays and transfers. Their surgeons, like Dr. Fevzi Akkan, performed Turkey’s first bionic eye surgery. This high surgical volume ensures clinicians are familiar with the latest cell delivery techniques.
| Turkey | Thailand | ||
| Stem cell therapy for retina | from AUD $14,353 | from AUD $11,482 | from AUD $9,329 |
No hidden fees – just official clinic prices. Pay at the clinic for Stem cell therapy for retina upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem cell therapy for retina and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem cell therapy for retina journey.
Dr. Muhammet Derda Ozer is an associate professor and ophthalmologist at his JCI-accredited clinic in Istanbul. He completed a fellowship in vitreo-retina at the University of Kansas Medical School. Dr. Ozer has performed over 25,000 surgical procedures during his clinical practice. He holds the Advanced Examination certificate from the International Council of Ophthalmology.
Dr. Yasar Dag is an ophthalmologist at VM Medical Park Florya Hospital in Istanbul. He specializes in cataract surgery, corneal diseases, and strabismus. Dr. Dag previously served as a specialist at Basaksehir Cam and Sakura City Hospital. He is a member of the Turkish Ophthalmological Association.
Dr. Yasar Dag is an ophthalmologist at Valued Med Hub Hospitals in Istanbul. He specializes in cataract surgery and corneal transplant procedures. Dr. Dag completed vitrectomy training at Ulucanlar Eye Training and Research Hospital. He treats complex conditions like strabismus, glaucoma, and retinopathy of prematurity.
Professor Ali Riza Cenk Celebi is a highly decorated ophthalmologist who completed a fellowship at Harvard Medical School and specialises in complex ocular surface treatments.
Stem cell therapy for the retina in Turkey is a safe, locally approved option for patients with limited alternatives. While considered experimental by global standards, JCI-accredited facilities use GMP-certified labs for autologous treatments. Clinics operate under strict government permits for international retinal care.
Bookimed Expert Insight: Istanbul has become a high-volume hub for these treatments. The Dunyagoz network alone serves 66,000+ patients annually. Their packages often include a 2-day hospital stay. This stay is longer than the standard outpatient care seen elsewhere.
Patient Consensus: Patients see treatment in Turkey as an experimental path for conditions like Retinitis Pigmentosa. They suggest checking the exact cell types used. Patients also recommend requesting published safety data before booking travel.
Stem cell therapy in Turkey targets degenerative retinal conditions. These include Retinitis Pigmentosa, Age-Related Macular Degeneration, and Stargardt disease. Specialist clinics in Istanbul use mesenchymal stem cells via intravitreal injections to repair tissues. Procedures typically cost $10,000 to $16,000. This offers 71% savings compared to Australian averages.
Bookimed Expert Insight: Many providers market broad retina care. However, the Dunyagoz network serves 66,000+ patients annually and maintains specific ocular oncology units. Choosing a dedicated eye hospital ensures access to surgeons like Dr Muhammet Derda Ozer. He has performed 25,000+ procedures.
Patient Consensus: Patients find Retinitis Pigmentosa the most treated condition in Turkey. They value these options when local Australian treatments are limited. Most aim for stabilising vision. They appreciate clinics providing clear eligibility criteria for various inherited retinal dystrophies.
Stem cell therapy for the retina in Turkey involves injecting regenerative cells into or behind the eye. It is used to treat conditions like retinitis pigmentosa. Specialist clinics in Istanbul use intravitreal or retrobulbar injections. They deliver autologous stem cells typically sourced from the patient's own fat tissue.
Bookimed Expert Insight: This is often thought of as a quick outpatient visit. However, Dunyagoz Eye Hospital packages include 2 days of hospitalisation. This time allows specialists to monitor for immediate reactions after the injection. This is a significant safety advantage over clinics offering same-day discharge.
Patient Consensus: Patients often highlight the convenience of all-inclusive packages in Turkey. These bundle specialist consultations with hospital stays and airport transfers. They appreciate clear communication about treatment goals for degenerative retinal conditions.
Expected success rates for retinal stem cell therapy in Turkey typically range from 49% to 85%. Recent data shows nearly 49% of retinitis pigmentosa patients experience better visual acuity. Leading Istanbul clinics like Dunyagoz treat 66,000+ patients annually using JCI-accredited protocols.
Bookimed Expert Insight: While general success rates look promising, patients should look for experienced surgeons. Dr. Muhammet Derda Ozer has performed 25,000+ procedures. He completed a vitreo-retina fellowship at the University of Kansas Medical School. This training at a major US academic centre often means higher precision in sub-retinal injections.
Patient Consensus: Outcome reality in Turkey is described as highly individual. Success often means stabilising vision rather than a full cure. Patients suggest asking clinics for specific trial data rather than relying on general percentages.